Great West Life Assurance CO Jounce Therapeutics, Inc. Transaction History

Great West Life Assurance CO

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 12, 2019	SELL	$2.69 - $6.71 $2,421 - $6,039	-900 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$11.17 - $16.99 $10,053 - $15,290	900	900 $14,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.